BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33303696)

  • 1. Gene coexpression networks reveal novel molecular endotypes in alpha-1 antitrypsin deficiency.
    Chu JH; Zang W; Vukmirovic M; Yan X; Adams T; DeIuliis G; Hu B; Mihaljinec A; Schupp JC; Becich MJ; Hochheiser H; Gibson KF; Chen ES; Morris A; Leader JK; Wisniewski SR; Zhang Y; Sciurba FC; Collman RG; Sandhaus R; Herzog EL; Patterson KC; Sauler M; Strange C; Kaminski N;
    Thorax; 2021 Feb; 76(2):134-143. PubMed ID: 33303696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency.
    Esquinas C; Janciauskiene S; Gonzalo R; Mas de Xaxars G; Olejnicka B; Belmonte I; Barrecheguren M; Rodriguez E; Nuñez A; Rodriguez-Frias F; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3381-3390. PubMed ID: 29238183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
    Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
    Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency.
    Jarosch I; Hitzl W; Koczulla AR; Wencker M; Welte T; Gloeckl R; Janciauskiene S; Kenn K
    Respir Med; 2017 Sep; 130():98-101. PubMed ID: 29206641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function.
    Kokturk N; Khodayari N; Lascano J; Riley EL; Brantly ML
    Respir Res; 2023 Feb; 24(1):40. PubMed ID: 36732772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ.
    Franciosi AN; Carroll TP; McElvaney NG
    Thorax; 2021 Mar; 76(3):298-301. PubMed ID: 32917839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in managing COPD related to α
    Craig TJ; Henao MP
    Allergy; 2018 Nov; 73(11):2110-2121. PubMed ID: 29984428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
    Beletic A; Dudvarski-Ilic A; Milenkovic B; Nagorni-Obradovic L; Ljujic M; Djordjevic V; Mirkovic D; Radojkovic D; Majkic-Singh N
    Biochem Med (Zagreb); 2014; 24(2):293-8. PubMed ID: 24969923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
    Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
    Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small airways disease in patients with alpha-1 antitrypsin deficiency.
    Toumpanakis D; Usmani OS
    Respir Med; 2023 May; 211():107222. PubMed ID: 36965591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
    Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
    Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.
    Miravitlles M; Turner AM; Torres-Duran M; Tanash H; Rodríguez-García C; López-Campos JL; Chlumsky J; Guimaraes C; Rodríguez-Hermosa JL; Corsico A; Martinez-González C; Hernández-Pérez JM; Bustamante A; Parr DG; Casas-Maldonado F; Hecimovic A; Janssens W; Lara B; Barrecheguren M; González C; Stolk J; Esquinas C; Clarenbach CF
    Respir Res; 2022 Dec; 23(1):352. PubMed ID: 36527073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.
    O'Brien ME; Fee L; Browne N; Carroll TP; Meleady P; Henry M; McQuillan K; Murphy MP; Logan M; McCarthy C; McElvaney OJ; Reeves EP; McElvaney NG
    Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency.
    Koczulla AR; Jonigk D; Wolf T; Herr C; Noeske S; Klepetko W; Vogelmeier C; von Neuhoff N; Rische J; Wrenger S; Golpon H; Voswinckel R; Luisetti M; Ferrarotti I; Welte T; Janciauskiene S
    Orphanet J Rare Dis; 2012 May; 7():29. PubMed ID: 22621770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in understanding and treating COPD related to α
    Henao MP; Craig TJ
    Expert Rev Respir Med; 2016 Dec; 10(12):1281-1294. PubMed ID: 27771979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
    Lascano JE; Campos MA
    Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
    Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
    Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.
    Banga A; Gildea T; Rajeswaran J; Rokadia H; Blackstone EH; Stoller JK
    Am J Respir Crit Care Med; 2014 Aug; 190(3):274-81. PubMed ID: 25003824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.